IP Library Granted Patent US 9,212,386
Granted Patent B2
US 9,212,386 · App. 13/553,011 · Granted Dec 15, 2015

Enzymatic cleavage based lateral flow assays

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,212,386
App. No.
13/553,011
Granted
Dec 15, 2015
Kind
B2
Abstract

Methods and devices for detecting a target enzyme include an anchored or trapped peptide complex. The peptide complex includes an anchor particle immobilized on a sample analysis device or trapped in a reaction receptacle including a filter, a peptide, with at least one enzyme cleavage site for a target enzyme, bound to the anchor particle, at least one detectable label, and at least one first tag bound to the peptide on a side of the enzyme cleavage site opposite the anchor particle. When the target enzyme is present in the sample, the enzyme cleaves the peptide at the enzyme cleavage site, permitting the cleaved peptide to reach the test zone of a sample analysis device such that the first tag binds to the immobilized second tag and a signal is detected at the test zone.

Claims (49)

1. A lateral flow assay system for detecting a target enzyme in a sample, comprising:

a) a reaction receptacle comprising:

i) a tube and an extraction dropper;

ii) at least one chamber for reaction between the sample and a trapped peptide complex, wherein the trapped peptide complex comprises:

A) a trappable particle;

B) a peptide bound to the trappable particle, wherein the peptide includes at least one enzyme cleavage site for a target enzyme;

C) at least one detectable label coupled to the peptide; and

D) at least one first tag bound to the peptide on a side of the enzyme cleavage site opposite the trappable particle; and

iii) at least one filter located in the extraction dropper, with a pore size that is smaller than a size of the trappable particle;

wherein the tube mates with the extraction dropper to create the chamber; and

b) a sample analysis device comprising:

i) a sample application zone for receiving the reacted sample and peptide from the reaction receptacle; and

ii) a test zone comprising at least one immobilized second tag that binds to the first tag;

wherein, when the target enzyme is present in the sample, the enzyme cleaves the peptide at the enzyme cleavage site such that the peptide can pass through the filter and be transferred from the reaction receptacle to the sample application zone of the sample analysis device, and the first tag binds to the immobilized second tag in the test zone such that the label is detectable in the test zone; and

wherein, when the target enzyme is not present in the sample, the peptide is trapped in the reaction receptacle by the filter and is not transferred to the sample analysis device, such that there is no detectable signal in the test zone when an assay has been run.

2. The lateral flow assay system of claim 1 , wherein the sample analysis device is a chromatographic test strip.

3. The lateral flow assay system of claim 1 , wherein the detectable label is a visible label.

4. The lateral flow assay system of claim 1 , wherein the peptide is dyed with the detectable label.

5. The lateral flow assay system of claim 1 , wherein the detectable label is bound to the peptide on a side of the enzyme cleavage site opposite the trappable particle.

6. The lateral flow assay system of claim 1 , wherein the first tag and the second tag comprise a pair selected from the group consisting of:

a) a first biotin tag and a second immobilized tag selected from the group consisting of avidin, neutravidin, and streptavidin;

b) a first tag selected from the group consisting of avidin, neutravidin, and streptavidin and a second biotin immobilized tag;

c) a first lectin tag and a second glycosyl moiety immobilized tag; and

d) a first glyosyl moiety tag and a second lectin immobilized tag.

7. The lateral flow assay system of claim 1 , wherein the extraction dropper comprises a tip that transfers the reacted sample from the reaction receptacle to the sample analysis device.

8. The lateral flow assay system of claim 1 , wherein the target enzyme is an enzyme from B. anthracis.

9. The lateral flow assay system of claim 1 , wherein the enzyme cleavage site comprises a BIKKAM peptide selective for B. anthracis.

10. A lateral flow assay system for detecting an enzyme from B. anthracis in a sample, comprising:

a) a reaction receptacle comprising:

i) at least one tube including at least one chamber for reaction between the sample and a trapped peptide complex, wherein the trapped peptide complex comprises:

A) a trappable particle;

B) a peptide bound to the trappable particle, wherein the peptide includes at least one enzyme cleavage site for the enzyme from B. anthracis;

C) at least one detectable label coupled to the peptide; and

D) at least one first tag bound to the peptide on a side of the enzyme cleavage site opposite the trappable particle; and

ii) at least one filter with a pore size that is smaller than a size of the trappable particle; and

b) a sample analysis device comprising:

i) a sample application zone for receiving the reacted sample and peptide from the reaction receptacle; and

ii) a test zone comprising at least one immobilized second tag that binds to the first tag;

wherein, when the enzyme from B. anthracis is present in the sample, the enzyme cleaves the peptide at the enzyme cleavage site such that the peptide can pass through the filter and be transferred from the reaction receptacle to the sample application zone of the sample analysis device, and the first tag binds to the immobilized second tag in the test zone such that the label is detectable in the test zone; and

wherein, when the enzyme from B. anthracis is not present in the sample, the peptide is trapped in the reaction receptacle by the filter and is not transferred to the sample analysis device, such that there is no detectable signal in the test zone when an assay has been run.

11. The lateral flow assay system of claim 10 , wherein the sample analysis device is a chromatographic test strip.

12. The lateral flow assay system of claim 1 , wherein the detectable label is a visible label.

13. The lateral flow assay system of claim 10 , wherein the peptide is dyed with the detectable label.

14. The lateral flow assay system of claim 10 , wherein the detectable label is bound to the peptide on a side of the enzyme cleavage site opposite the trappable particle.

15. The lateral flow assay system of claim 10 , wherein the first tag and the second tag comprise a pair selected from the group consisting of:

a) a first biotin tag and a second immobilized tag selected from the group consisting of avidin, neutravidin, and streptavidin;

b) a first tag selected from the group consisting of avidin, neutravidin, and streptavidin and a second biotin immobilized tag;

c) a first lectin tag and a second glycosyl moiety immobilized tag; and

d) a first glyosyl moiety tag and a second lectin immobilized tag.

Assignments (4)
SECURITY INTEREST Recorded Dec 20, 2018
From: RAPID PATHOGEN SCREENING, INC.; RPS DIAGNOSTICS, INC.
To: LUMOS DIAGNOSTICS HOLDINGS PTY LTD
Reel/Frame 047834/0030 →
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2018
From: ROS ACQUISITION OFFSHORE LP
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 047834/0367 →
SECURITY INTEREST Recorded Oct 10, 2014
From: RAPID PATHOGEN SCREENING, INC.
To: ROS ACQUISITION OFFSHORE LP
Reel/Frame 033929/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2012
From: BABU, UMA MAHESH; SAMBURSKY, ROBERT P.; VANDINE, ROBERT W.
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 028594/0042 →